Hoogenboom HR - Search Results

1

A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization.

Hufton SE, Moerkerk PT, Brandwijk R, de Bruïne AP, Arends JW, Hoogenboom HR. Hufton SE, et al. Among authors: hoogenboom hr. FEBS Lett. 1999 Dec 10;463(1-2):77-82. doi: 10.1016/s0014-5793(99)01578-1. FEBS Lett. 1999. PMID: 10601642 Free article.

2

Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer.

Van Beijnum JR, Moerkerk PT, Gerbers AJ, De Bruïne AP, Arends JW, Hoogenboom HR, Hufton SE. Van Beijnum JR, et al. Among authors: hoogenboom hr. Int J Cancer. 2002 Sep 10;101(2):118-27. doi: 10.1002/ijc.10584. Int J Cancer. 2002. PMID: 12209988

3

Selection of phage-displayed fab antibodies on the active conformation of ras yields a high affinity conformation-specific antibody preventing the binding of c-Raf kinase to Ras.

Horn IR, Wittinghofer A, de Bruïne AP, Hoogenboom HR. Horn IR, et al. Among authors: hoogenboom hr. FEBS Lett. 1999 Dec 10;463(1-2):115-20. doi: 10.1016/s0014-5793(99)01617-8. FEBS Lett. 1999. PMID: 10601649 Free article.

4

Antibody phage display technology and its applications.

Hoogenboom HR, de Bruïne AP, Hufton SE, Hoet RM, Arends JW, Roovers RC. Hoogenboom HR, et al. Immunotechnology. 1998 Jun;4(1):1-20. doi: 10.1016/s1380-2933(98)00007-4. Immunotechnology. 1998. PMID: 9661810 Review.

5

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies.

de Haard HJ, van Neer N, Reurs A, Hufton SE, Roovers RC, Henderikx P, de Bruïne AP, Arends JW, Hoogenboom HR. de Haard HJ, et al. Among authors: hoogenboom hr. J Biol Chem. 1999 Jun 25;274(26):18218-30. doi: 10.1074/jbc.274.26.18218. J Biol Chem. 1999. PMID: 10373423 Free article.

6

Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands.

Hufton SE, Moerkerk PT, Meulemans EV, de Bruïne A, Arends JW, Hoogenboom HR. Hufton SE, et al. Among authors: hoogenboom hr. J Immunol Methods. 1999 Dec 10;231(1-2):39-51. doi: 10.1016/s0022-1759(99)00139-8. J Immunol Methods. 1999. PMID: 10648926

7

Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands.

Hufton SE, van Neer N, van den Beuken T, Desmet J, Sablon E, Hoogenboom HR. Hufton SE, et al. Among authors: hoogenboom hr. FEBS Lett. 2000 Jun 23;475(3):225-31. doi: 10.1016/s0014-5793(00)01701-4. FEBS Lett. 2000. PMID: 10869561 Free article.

8

Serological antigen selection of phage displayed colorectal tumour cDNA libraries.

Hufton SE, Moerkerk P, de Bruine A, Arends JW, Hoogenboom HR. Hufton SE, et al. Among authors: hoogenboom hr. Biochem Soc Trans. 1998 Feb;26(1):S5. doi: 10.1042/bst026s005. Biochem Soc Trans. 1998. PMID: 10909763 No abstract available.

9

Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma.

Roovers RC, van der Linden E, de Bruïne AP, Arends JW, Hoogenboom HR. Roovers RC, et al. Among authors: hoogenboom hr. Eur J Cancer. 2001 Mar;37(4):542-9. doi: 10.1016/s0959-8049(00)00432-9. Eur J Cancer. 2001. PMID: 11267865

10

In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody.

Roovers RC, van der Linden E, de Bruïne AP, Arends JW, Hoogenboom HR. Roovers RC, et al. Among authors: hoogenboom hr. Cancer Immunol Immunother. 2001 Mar;50(1):51-9. doi: 10.1007/s002620000160. Cancer Immunol Immunother. 2001. PMID: 11315510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters